πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7824697

High concentration baclofen preparations

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7825269

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816538

Dimeric small molecule potentiators of apoptosis

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7816131

Cancer specific promoters

The Board of Regents of the University of Texas System Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7811592

Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequen

The Board of Regents of the University of Texas System Β· Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807179

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807651

Methods and materials for pain management

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807618

Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807383

Diagnosing and treating hormone resistant cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7807346

High-throughput assay for virus entry and drug screening

The Board of Regents of the University of Texas System Β· Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7803363

Attenuated Francisella bacteria

The Board of Regents of the University of Texas System Β· Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7799518

Nucleic acid molecules and proteins for the identification, assessment, prevention, and th

The Board of Regents of the University of Texas System Β· Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7795389

Antagonizing TGF-beta activity with various ectodomains TGF-beta receptors used in combina

The Board of Regents of the University of Texas System Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7795305

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790860

Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7790159

Methods, combinations and kits for treating viral infections using immunoconjugates and an

The Board of Regents of the University of Texas System Β· Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7785597

VMP-like sequences of pathogenic Borrelia

The Board of Regents of the University of Texas System Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7781565

Compositions and methods related to profiling a plurality of cells based on peptide bindin

The Board of Regents of the University of Texas System Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7781413

SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

The Board of Regents of the University of Texas System Β· Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7776816

Preserving hypoxic tissue

The Board of Regents of the University of Texas System Β· Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7771732

Polymer network compositions and associated methods

The Board of Regents of the University of Texas System Β· Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7754872

Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotides

The Board of Regents of the University of Texas System Β· Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7745468

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted